Previous 10 | Next 10 |
The following slide deck was published by Enlivex Therapeutics Ltd. in conjunction with this event. For further details see: Enlivex (ENLV) Investor Presentation - Slideshow
Interpace Biosciences (IDXG) +72% after completing an independent investigation into complaints and finds it unsubstantiated.Allscripts Healthcare Solutions (MDRX) +38% on announcing to sell its CarePort Health business to WellSky.VOXX International Corporation (VOXX) ...
Gainers: Medigus (MDGS) +74%.PEDEVCO (PED) +46%.Larimar Therapeutics (LRMR) +23%.Oblong (OBLG) +23%.Blonder Tongue Laboratories (BDR) +21%.BiondVax Pharmaceuticals (BVXV) +19%.Enlivex Therapeutics (ENLV) +19%.Aileron Therapeutics (ALRN) +17%.MoneyGram International (MGI) +15%.ReneSo...
Gainers: Medigus (MDGS) +84%, Altimmune (ALT) +25%, Enlivex Therapeutics (ENLV) +16%, BiondVax Pharmaceuticals (BVXV) +16%, Aileron Therapeutics (ALRN) +15%.Losers: Gossamer Bio (GOSS) -34%, Avenue Therapeutics (ATXI) -17%, Emergent ...
Israeli Ministry of Health has signed-off Enlivex Therapeutics's ([[ENLV]] +16.4%) proposed investigator-initiated Phase 2 trial evaluating Allocetra in severe and critical COVID-19 patients.The 24-subject study is designed to assess Allocetra in combination with standard of ca...
Nes Ziona, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today reported that the Israeli Ministry of Health authorized the initiation of a proposed investigator-initiated Phase II ...
SOS Limited (SOS) +36%.The Peck Company Holdings (PECK) +20% after announcing $7.64M contract.Enlivex Therapeutics (ENLV) +12%.Apex Global Brands (APEX) +12%.Altimmune (ALT) +11%.Sunworks (SUNW) +10%.Blonder Tongue Laboratories (BDR) +9% after announcing patent grant from ...
Gainers: Taiwan Liposome (TLC) +36%. Ocular Therapeutix (OCUL) +21%. LogicBio Therapeutics (LOGC) +11%. American Well (AMWL) +11%. Tiziana Life Sciences (TLSA) +11%.Losers: Enlivex Therapeutics (ENLV) -12%. Aytu BioScience (AYTU) -12%. Xtant Medical (XTNT) -11%. ARCA bioph...
Electro-Sensors (ELSE) -24%.CleanSpark (CLSK) -24% after pricing equity offering.Asia Pacific Wire & Cable (APWC) -17%.RCM Technologies (RCMT) -13%.Ashford Hospitality Trust (AHT) -12% after shareholders OK issuance of up to 126M shares.Aytu BioScience (AYTU) -11%...
Gainers: Greenpro Capital (GRNQ) +85%.MyoKardia (MYOK) +58%.Westwater Resources (WWR) +53%.Eidos Therapeutics (EIDX) +40%.Scully Royalty (SRL) +34%.Enlivex Therapeutics (ENLV) +28%.Humanigen (HGEN) +24%.Corvus Pharmaceuticals (CRVS) +22%.Piedmont Lithium (PLL) +22%.Pulse Biosciences (PLS...
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NASDAQ Market:
Enlivex Therapeutics Ltd. Website:
• First study of Allocetra TM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis 1 , and has limited treatment options Nes-Ziona, Israel, July 23, 2024 (GLOB...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...